|
Young people are intentionally taking drink and drugs for better sex
May 09, 2008Teenagers and young adults across Europe drink and take drugs as part of deliberate sexual strategies. Findings published today in BioMed Central's open access journal, BMC Public Health, reveal that a third of 16-35 year old males and a quarter of females surveyed are drinking alcohol to increase their chances of sex, while cocaine, ecstasy and cannabis are intentionally used to enhance sexual arousal or prolong sex.
The study was conducted by researchers in public health and social sciences from across Europe. More than 1300 people aged between 16 and 35 and who routinely socialise in nightlife settings completed anonymous questionnaires.
Virtually all of the survey participants had drunk alcohol with most having had their first drink when 14 or 15 years old. Three quarters of the respondents had tried or used cannabis, while around 30 percent had at least tried ecstasy or cocaine.
Overall, alcohol was most likely to be used to facilitate a sexual encounter, while cocaine and cannabis were more likely to be utilised to enhance sexual sensations and arousal.
Despite these perceived sexual "benefits", drunkenness and drug use were strongly associated with an increase in risk taking behaviour and feeling regretful about having sex while under the influence of alcohol or drugs. Thus, participants who had been drunk in the past four weeks were more likely to have had five or more partners, sex without a condom and to have regretted sex after drink or drugs in the past 12 months. Cannabis, cocaine or ecstasy use was linked to similar consequences.
"Trends in recent decades have resulted in recreational drug use and binge drinking becoming routine features of European nightlife," says lead author Mark Bellis, from Liverpool John Moores University. "Millions of young Europeans now take drugs and drink in ways which alter their sexual decisions and increase their chances of unsafe sex or sex that is later regretted. Yet despite the negative consequences, we found many are deliberately taking these substances to achieve quite specific sexual effects."
Individuals were significantly more likely to have had sex under 16 years if they had used alcohol, cannabis, cocaine or ecstasy before that age. Girls in particular were as much as four times as likely to have had sex before the age of 16 if they drank alcohol or used cannabis under 16.
"Sexual activity accompanied by substance use is not just incidental, but often sexually motivated," says co-author, consultant psychiatrist Amador Calafat. "Interventions addressing sexual health are often developed, managed and implemented independently from those addressing substance use, and vice versa. However, young people often see alcohol, drugs and sex all as part of the same social experience and addressing these issues requires an equally joined up approach. "
BioMed Central
Overall, alcohol was most likely to be used to facilitate a sexual encounter, while cocaine and cannabis were more likely to be utilised to enhance sexual sensations and arousal.
Despite these perceived sexual "benefits", drunkenness and drug use were strongly associated with an increase in risk taking behaviour and feeling regretful about having sex while under the influence of alcohol or drugs. Thus, participants who had been drunk in the past four weeks were more likely to have had five or more partners, sex without a condom and to have regretted sex after drink or drugs in the past 12 months. Cannabis, cocaine or ecstasy use was linked to similar consequences.
"Trends in recent decades have resulted in recreational drug use and binge drinking becoming routine features of European nightlife," says lead author Mark Bellis, from Liverpool John Moores University. "Millions of young Europeans now take drugs and drink in ways which alter their sexual decisions and increase their chances of unsafe sex or sex that is later regretted. Yet despite the negative consequences, we found many are deliberately taking these substances to achieve quite specific sexual effects."
Individuals were significantly more likely to have had sex under 16 years if they had used alcohol, cannabis, cocaine or ecstasy before that age. Girls in particular were as much as four times as likely to have had sex before the age of 16 if they drank alcohol or used cannabis under 16.
"Sexual activity accompanied by substance use is not just incidental, but often sexually motivated," says co-author, consultant psychiatrist Amador Calafat. "Interventions addressing sexual health are often developed, managed and implemented independently from those addressing substance use, and vice versa. However, young people often see alcohol, drugs and sex all as part of the same social experience and addressing these issues requires an equally joined up approach. "
BioMed Central
Drugs News and Current Drugs Events RSSCelebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
Celecoxib, the anti-inflammatory medication also known by the trade name Celebrex, has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung, according to a study from The University of Texas M. D. Anderson Cancer Center.
New Mount Sinai research tracks effects of addictive drugs on brain
Mount Sinai researchers may have unlocked the key to better understanding the effect addictive drugs have on the human brain.
Adding epratuzumab to standard therapy
Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma.
Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
Researchers in the North Central Cancer Treatment Group (NCCTG) have shown that patients who receive intravenous calcium and magnesium before and after the chemotherapy drug oxaliplatin for the treatment of advanced colon cancer experience a significantly reduced incidence and severity of neurological side effects (neurotoxicity).
Novel enzyme inhibitor paves way for new cancer drug
Combining natural organic atoms with metal complexes, scientists at The Wistar Institute have developed a new type of enzyme inhibitor capable of blocking a biochemical pathway that plays a key role in cancer development.
Compound has potential for new class of AIDS drugs
Researchers have developed what they believe is the first new mechanism in nearly 20 years for inhibiting a common target used to treat all HIV patients, which could eventually lead to a new class of AIDS drugs.
Researchers find first conclusive evidence of Alzheimer's-like brain tangles in nonhuman primates
Researchers at the Yerkes National Primate Research Center, Emory University, have discovered the first conclusive evidence of Alzheimer's-like neurofibrillary brain tangles in an aged nonhuman primate.
Targeted therapy plus chemotherapy may pack 1-2 punch against melanoma
By targeting and disabling a protein frequently found in melanoma tumors, doctors may be able to make the cancer more vulnerable to chemotherapy, according to a new study by researchers in the Duke Comprehensive Cancer Center.
Researchers Find New Treatment for Hepatitis C
Researchers at the OU Health Sciences Center have found a new use for an old drug. Their findings appear online Friday in the American Journal of Gastroenterology.
Families shed light on likely causative gene for Alzheimer's
The genetic profile of two large Georgia families with high rates of late-onset Alzheimer's disease points to a gene that may cause the disease, researchers say.
More Drugs News Articles
| © 2008 BrightSurf.com |